| 5FU | 5-fluorouracil | n | diffusional exponent |
| AA | ascorbic acid | NIR | near-infrared region |
| CTAB | cetyltrimethylammonium bromide | NVCL | N-vinylcaprolactam |
| DL | drug loading | NVP | N-vinylpyrrolidone |
| DMA | dynamic mechanical analysis | PBS | phosphate-buffered saline |
| DR | drug release | PNVCL | poly(N-vinylcaprolactam) |
| DSC | differential scanning calorimetry | Q | swelling ratio |
| EE | encapsulation efficiency | Tg | glass transition temperature |
| F | fractional drug release | TGA | thermogravimetric analysis |
| GNRDs | gold nanorods | UV–Vis | UV–Vis spectroscopy |
| IRGACURE 651® | 2,2-dimethoxy-2-phenylacetophenone | Vd | volume of dry hydrogel |
| k | release rate constant | VPTT | volume phase transition temperature |
| LAMA | 2-lactobionamidoethyl methacrylate | Vs | volume of swelled hydrogel |
| LSPR | localized surface plasmon resonance | Wd | dry hydrogel mass |
| M 0 | initial mass of drug | Ws | swelled hydrogel mass |
| MD | mass of drug | Wsol | weight of the absorbed solvent |
| MDh | mass of drug in the hydrogel | ρd | density of the dry hydrogel |
| Mt | mass of drug at time t | ρso | density of the solvent |